Athira Pharma Inc (ATHA): רווח למניה בשנים עשר החודשים האחרונים

The prospects for Athira Pharma, Inc. (ATHA) depend on the success of Alzheimer's drug trials and the volume of capital. The rolling earnings per share over the year visualizes management efficiency, where -9.65 represents the current level of the metric. Rising nationalism and sanctions on biomaterials hinder software expansion, yet the demand for neuromedicine provides resilience to market cycles.
פילוחי מדדים מקיפים ואנליטיקה עבור Athira (ATHA)

To separate fundamental stability from market noise, capital requires an analysis of real yield. This metric measures the net profit distributed per share per year, excluding one-time accounting distortions. The current annual net income per share reflects the efficiency of capital generation. For Athira Pharma, Inc. (ATHA), this is critical, as the colossal demand for Alzheimer's therapy will ensure a sharp increase in profits following clinical trials.